SCHEMBL4932637

SCHEMBL4932637

CCCNc1cc(Cl)cc(COc2c(Cl)cc(C(=O)NCC(=O)O)cc2Cl)c1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD17B10 Q99714 1/20 0.40
ALDH1A1 P00352 4/20 0.38
MEN1 O00255 3/20 0.38
KMT2A Q03164 3/20 0.38
MAPT P10636 3/20 0.38
RAB9A P51151 2/20 0.38
GAA P10253 2/20 0.38
HPGD P15428 2/20 0.38
LMNA P02545 2/20 0.38
NPC1 O15118 1/20 0.38
ABL1 P00519 1/20 0.38
RIN1 Q13671 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
KDM4E B2RXH2 3/20 0.37
MRGPRX4 Q96LA9 2/20 0.36
FABP4 P15090 1/20 0.36
PLAU P00749 1/20 0.35
CYP1A2 P05177 1/20 0.35
CYP3A4 P08684 1/20 0.35
CYP2D6 P10635 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5717763 0.95 HSD17B10 (0.37) HSD17B10ALDH1A1MEN1KMT2AMAPT
SCHEMBL4934594 0.94 MRGPRX4 (0.39) HSD17B10ALDH1A1MEN1KMT2AMAPT
SCHEMBL4926987 0.91 THRA (0.41) HSD17B10ALDH1A1MEN1KMT2AMAPT
SCHEMBL4930987 0.91 THRB (0.41) MEN1KMT2AMAPTRAB9AHPGD
SCHEMBL4932166 0.91 HSD17B10 (0.39) HSD17B10ALDH1A1MEN1KMT2AMAPT
SCHEMBL4932449 0.91 HSD17B10 (0.39) HSD17B10ALDH1A1MEN1KMT2AMAPT
SCHEMBL4931839 0.88 TRPA1 (0.46) ALDH1A1MRGPRX4CYP1A2
SCHEMBL4931357 0.88 THRA (0.48) ALDH1A1MEN1KMT2AMAPTRAB9A
SCHEMBL4929539 0.87 MRGPRX4 (0.39) HSD17B10ALDH1A1MEN1KMT2AMAPT
SCHEMBL4926320 0.87 ALDH1A1 (0.40) HSD17B10ALDH1A1MEN1KMT2AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080221210-A1 Thyroid Receptor Agonists KARO BIO AB (SE) 2008-09-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080221210-A1 Thyroid Receptor Agonists TSHR, TRHR, THRA HSD17B10 1738/4885ALDH1A1 1818/4885MEN1 773/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.